L & S Advisors Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

L & S Advisors Inc

$771 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $2 Million - $3.51 Million	-24,064 Reduced 92.79%	1,870 $272,000
Q1 2022 May 11, 2022	SELL	$110.08 - $142.92 $1.82 Million - $2.36 Million	-16,544 Reduced 38.95%	25,934 $3.08 Million
Q4 2021 Feb 09, 2022	SELL	$99.73 - $148.48 $1.16 Million - $1.73 Million	-11,647 Reduced 21.52%	42,478 $5.85 Million
Q3 2021 Nov 09, 2021	SELL	$98.85 - $138.91 $758,080 - $1.07 Million	-7,669 Reduced 12.41%	54,125 $7.52 Million
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $196,221 - $313,274	2,983 Added 5.07%	61,794 $6 Million
Q1 2021 May 10, 2021	SELL	$64.07 - $91.75 $93,862 - $134,413	-1,465 Reduced 2.43%	58,811 $4.02 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $148,619 - $224,380	-2,284 Reduced 3.65%	60,276 $5.17 Million
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $354,417 - $467,933	-6,003 Reduced 8.76%	62,560 $4.07 Million
Q2 2020 Aug 13, 2020	SELL	$29.01 - $74.23 $1.3 Million - $3.32 Million	-44,688 Reduced 39.46%	68,563 $5.01 Million
Q1 2020 May 13, 2020	BUY	$27.51 - $57.29 $1.31 Million - $2.73 Million	47,718 Added 72.82%	113,251 $3.85 Million
Q4 2019 Feb 13, 2020	BUY	$40.86 - $57.65 $220,930 - $311,713	5,407 Added 8.99%	65,533 $3.57 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $812,715 - $1.08 Million	-21,742 Reduced 26.56%	60,126 $2.51 Million
Q2 2019 Aug 13, 2019	BUY	$39.79 - $67.01 $1.57 Million - $2.64 Million	39,446 Added 92.98%	81,868 $3.59 Million
Q1 2019 May 14, 2019	SELL	$34.52 - $53.29 $59,305 - $91,552	-1,718 Reduced 3.89%	42,422 $2.18 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $524,343 - $756,112	17,625 Added 66.47%	44,140 $1.63 Million
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $191,165 - $250,690	5,830 Added 28.18%	26,515 $996,000
Q2 2018 Aug 13, 2018	BUY	$23.62 - $42.29 $488,579 - $874,768	20,685 New	20,685 $817,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.

Account